NEW YORK (GenomeWeb News) – A University of Texas medical research center will collaborate with GenoLogics to develop an integrated software solution for use in its translational medical bioinformatics research programs, GenoLogics said today.
The Vancouver, British Columbia-based company said it will work with the Sealy Center for Molecular Medicine at the University of Texas Medical Branch at Galveston to develop biospecimen-management software.
The SCMM, which is part of the Institute for Translational Sciences, is focused on developing new tools for studying biomarkers and human diseases at the molecular level.
“In order to validate our biomarkers for common diseases, we needed to exchange information from clinical to research domains,” SCMM’s director of Biomarker Discovery, Kevin Rosenblatt, said in a statement.
To do that, Rosenblatt said, SMCC sought “a biomedical informatics solution that not only tracks our biospecimens, but also the clinical annotations and then connects to the data being generated in our research labs.”
The system that the company and the center develop will “bring it all together in a single platform,” he added.